SCHEMBL30686350

SCHEMBL30686350

CC1(C)CN(c2cnccc2C(=O)O)CCN1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LATS1 O95835 1/20 0.50
▸ PRKCQ Q04759 1/20 0.42
▸ CSNK1E P49674 4/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ KDM4C Q9H3R0 3/20 0.38
▸ KDM6B O15054 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KDM4A O75164 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ KDM4D Q6B0I6 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CDK4 P11802 8/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ CDK6 Q00534 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15770057 0.77 LATS1 (0.55) LATS1PRKCQCSNK1EHDAC1MAPT
SCHEMBL30686213 0.74 KMT2A (0.55) PRKCQCSNK1EHDAC1KDM4EMEN1
SCHEMBL30686207 0.74 PRKCQ (0.42) LATS1PRKCQCSNK1EHDAC1KDM4E
SCHEMBL30686366 0.74 LATS1 (0.40) LATS1PRKCQCSNK1EHDAC1MEN1
SCHEMBL28509680 0.74 KDM4C (0.49) KDM4CKDM6BKDM4EMEN1KDM4A
SCHEMBL29664704 0.73 KDM4C (0.47) KDM4CKDM6BKDM4EMEN1KDM4A
SCHEMBL18394720 0.73 KDM4C (0.47) KDM4CKDM6BKDM4EMEN1KDM4A
SCHEMBL18395417 0.71 SMN1; SMN2 (0.47) KDM4CKDM6BKDM4EMEN1KDM4A
SCHEMBL29575095 0.71 SMN1; SMN2 (0.47) KDM4CKDM6BKDM4EMEN1KDM4A
SCHEMBL31368899 0.70 LATS1 (0.39) LATS1PRKCQCSNK1EHDAC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532496-A1 NOVEL PAR-2 INHIBITORS Domain Therapeutics (FR) 2025-04-09 — — EP claimed
WO-2023233033-A1 NOVEL PAR-2 INHIBITORS DOMAIN THERAPEUTICS (FR) 2023-12-07 — — WO claimed
Send feedback